Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
159.28
+16.21 (11.33%)
Sep 17, 2026, 12:37 PM EDT - Market open
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $9.99 billion as of September 17, 2026. Its market cap has increased by 511.05% in one year.
Market Cap
9.99B
Enterprise Value
9.93B
1-Year Change
511.05%
Ranking
Category
Stock Price
$159.28
ChartMarket Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $9.99B, an increase of 2,581.07%. That is a compound annual growth rate of 51.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 9.99B | 414.95% |
| Dec 31, 2025 | 1.94B | -29.68% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 9.97B |
| Kymera Therapeutics | 9.67B |
| Cytokinetics | 9.65B |
| Arrowhead Pharmaceuticals | 9.29B |
| Protagonist Therapeutics | 9.24B |
| ABIVAX Société Anonyme | 9.10B |
| Vaxcyte | 8.75B |
| Praxis Precision Medicines | 8.63B |